Latest filing published 25 Jun 2018 for Aralez Pharmaceuticals Inc., €5,486.
Insider track record
Jennifer Lou Armstrong: trading record in brief
Jennifer Lou Armstrong appears in our data through filings on Aralez Pharmaceuticals Inc. shares, published by SEC (Form 4). Over a trading history stretching from 5 February 2016 to 22 June 2018, the count stands at 7 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 25 June 2018 came the latest disclosure, an option exercise for €5,486 in Aralez Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jennifer Lou Armstrong
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 21,750 shares@ CA$0.395.9% of flowCommon SharesTSXSEDI:3201761
- 15,031 shares@ CA$0.50275.3% of flowCommon SharesTSXSEDI:3184126
- 10,526 shares@ CA$1.8312.9% of flowCommon SharesTSXSEDI:3157852
- 21,750 shares@ CA$1.3354.3% of flowCommon SharesTSXSEDI:3025668
- 10,526 shares@ CA$2.2545.7% of flowCommon SharesTSXSEDI:2982157
- 14,899 shares@ CA$3.3436.9% of flowCommon SharesTSXSEDI:2855834
- Common SharesTSXSEDI:2787383
7 of 7 declarations
